ArticleCardiotoxic Effect of Adjuvant Subcutaneous versus Intravenous Trastuzumab in HER-2 Positive Breast Cancer
ArticleCardiotoxic Effect of Adjuvant Subcutaneous versus Intravenous Trastuzumab in HER-2 Positive Breast Cancer
ArticlePRECLINICAL DETECTION OF CHEMOTHERAPY INDUCED LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CANCER COLON BY TRANSTHORACIC ECHOCARDIOGRAPHY
ArticlePRECLINICAL DETECTION OF CHEMOTHERAPY INDUCED LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CANCER COLON BY TRANSTHORACIC ECHOCARDIOGRAPHY
ArticleECG changes as Cardiac Toxicity of Concurrent Trustuzumab and Paclitaxel in Adjuvant Treatment of HER-2 positive Breast Cancer
ArticleECG changes as Cardiac Toxicity of Concurrent Trustuzumab and Paclitaxel in Adjuvant Treatment of HER-2 positive Breast Cancer
ArticleAssessment of Radiotherapy Toxicity in Irradiated Internal Mammary Lymph Nodes in Breast Cancer Patients
ArticleAssessment of Radiotherapy Toxicity in Irradiated Internal Mammary Lymph Nodes in Breast Cancer Patients
ArticleAnthracycline-Related Cardiotoxicity in Patients with Acute Leukemia and Down syndrome: A retrospective study
ArticleAnthracycline-Related Cardiotoxicity in Patients with Acute Leukemia and Down syndrome: A retrospective study
ArticleRight Ventricle Function Evaluation by 2D Transthoracic-Echocardiography in Breast Cancer Patients Undergoing Anthracycline Chemotherapy, A Prospective Cohort Study
ArticleRight Ventricle Function Evaluation by 2D Transthoracic-Echocardiography in Breast Cancer Patients Undergoing Anthracycline Chemotherapy, A Prospective Cohort Study
ArticleEvaluation of the cardioprotective effect of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy
ArticleEvaluation of the cardioprotective effect of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy